Immunexcite Inc
Innate Bio, based in Waltham, MA, is pioneering a unique cancer immunotherapy that harnesses both the innate and adaptive immune systems to combat tumors effectively. Their innovative platform utilizes an engineered fungal carbohydrate linked to tumor-targeting monoclonal antibodies, promoting a robust immune response to eliminate tumor growth and metastasis.
The company's pre-clinical pipeline demonstrates significant advantages, including a strong intellectual property portfolio and successful optimization of lead programs. With applications in both solid and liquid tumors, Innate Bio aims to transform cancer treatment through their targeted approach that enhances existing therapies and provides a promising alternative within the cancer immunotherapy landscape.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.

